Boehringer Ingelheim launches three phase III trials in precision Oncology
Boehringer Ingelheim has initiated three Phase III clinical trials aimed at advancing…
UAE Approves New Oral Breast Cancer Treatment for Hormone-Resistant Cases
The UAE has approved AstraZeneca’s Etcamah, a new oral therapy for advanced…
Rigel Pharmaceuticals Signs Global Licensing Deal for VEPPANU™ Breast Cancer Treatment
Rigel Pharmaceuticals has entered an exclusive global licensing agreement with Arvinas and…
Johnson & Johnson expands access to liquid biopsy testing for lung cancer patients in the UAE
Johnson & Johnson expands access to liquid biopsy testing in the UAE,…
Regeneron and Telix Announce Strategic Radiopharma Collaboration
Regeneron and Telix Pharmaceuticals announce a strategic collaboration to develop next-generation radiopharmaceutical…
Less Invasive, More Precise: The Shift in Colorectal Cancer Care
In an exclusive interview at WHX Dubai 2026, Dr. Julio Garcia-Aguilar, Chief…
FDA Grants Breakthrough Therapy Designation to Novartis’ Ianalumab for Sjögren’s Disease
The FDA has granted Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s…
Breast Cancer: What you need to know
Breast cancer is a prevalent disease that affects millions worldwide. Understanding its…
Amgen’s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study
Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…
Datroway: A Novel TROP2‑Directed Therapy Approved for Lung Cancer
AstraZeneca and Daiichi Sankyo’s new antibody drug conjugate, Datroway (datopotamab deruxtecan), has received accelerated…
